Abstract
Influenza virus is a highly contagious respiratory virus also known as seasonal flu. This virus belongs to the Orthomyxoviridae family and its genome is composed of eight negative-sense RNA segments. The virus has two major surface proteins, hemagglutinin (HA) responsible for virus entry and neuraminidase (NA) release from host cells. Influenza virus infection has wide range of symptoms, from mild to severe, and results in complications such as pneumonia and respiratory failure, commonly associated with persons having compromised immune systems. The virus is transmitted through respiratory droplets released by infected individuals when they cough, sneeze, or talk. The virus undergoes frequent antigenic changes, which make it difficult to develop effective vaccines that provide long-lasting immunity. Antiviral medications, such as neuraminidase inhibitors, are available to treat influenza virus infections, but their effectiveness is limited. Influenza virus remains a significant public health threat, with the potential to cause epidemics and pandemics that can have serious global impacts. This review article is focused on better understanding the virus pathogenesis and develo** more effective interventions to prevent and treat influenza virus infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ablasser A, Poeck H, Anz D, Berger M, Schlee M, Kim S, Bourquin C, Goutagny N, Jiang Z, Fitzgerald KA, Rothenfusser S, Endres S, Hartmann G, Hornung V (2009) Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytes. J Immunol 182(11):6824–6833. https://doi.org/10.4049/JIMMUNOL.0803001
Acheson NH (2011) Fundamentals of molecular virology, 2nd edn. John Wiley & Sons, Inc.
Adeola OA, Olugasa BO, Emikpe BO (2017) Molecular detection of influenza A (H1N1) pdm09 viruses with M genes from human pandemic strains among Nigerian pigs, 2013–2015: implications and associated risk factors. Epidemiol Infect 145(16):3345–3360
Akarsu H, Burmeister WP, Petosa C, Petit I, Müller CW, Ruigrok RW, Baudin F (2003) Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J 22(18):4646–4655
Ampomah PB, Kong WT, Zharkova O, Chua SCJH, Perumal Samy R, Lim LH (2018) Annexins in influenza virus replication and pathogenesis. Front Pharmacol 9:1282
Ayllon J, García-Sastre A (2015) The NS1 protein: a multitasking virulence factor. Curr Top Microbiol Immunol 386:73–107
Belser JA, Katz JM, Tumpey TM (2011) The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4(5):575–579
Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J et al (2020) Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Lancet Infect Dis 20(1):80–91
Blumenkrantz D, Roberts KL, Shelton H, Lycett S, Barclay WS (2013) The short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferrets. J Virol 87(19):10539–10551
Boni MF, Zhou Y, Taubenberger JK, Holmes EC (2008) Homologous recombination is very rare or absent in human influenza A virus. J Virol 82(10):4807–4811
Borkenhagen LK, Salman MD, Ma MJ, Gray GC (2019) Animal influenza virus infections in humans: a commentary. Int J Infect Dis 88:113–119
Böttcher-Friebertshäuser E, Garten W, Matrosovich M, Klenk HD (2014) The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol 385:3–34
Bouvier NM, Palese P (2008) The biology of influenza viruses. Vaccine 26:D49–D53
Cady SD, Luo W, Hu F, Hong M (2009) Structure and function of the influenza A M2 proton channel. Biochemistry 48(31):7356–7364
Cady SD, Schmidt-Rohr K, Wang J, Soto CS, DeGrado WF, Hong M (2010) Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 463(7281):689–692
Caini S, Kusznierz G, Garate VV, Wangchuk S, Thapa B, de Paula Júnior FJ et al (2019) The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS One 14(9):e0222381
Campbell DJ, Koch MA (2011) Treg cells: patrolling a dangerous neighborhood. Nat Med 17(8):929–930
Cauldwell AV, Long JS, Moncorge O, Barclay WS (2014) Viral determinants of influenza A virus host range. J Gen Virol 95(6):1193–1210
Chen L, Sun L, Li R, Chen Y, Zhang Z, **ong C et al (2016) Is a highly pathogenic avian influenza virus H5N1 fragment recombined in PB1 the key for the epidemic of the novel AIV H7N9 in China, 2013? Int J Infect Dis 43:85–89
Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL (2018) Host immune response to influenza A virus infection. Front Immunol 9:320
Cheung PHH, Ye ZW, Lee TWT, Chen H, Chan CP, ** DY (2020) PB1-F2 protein of highly pathogenic influenza A (H7N9) virus selectively suppresses RNA-induced NLRP3 inflammasome activation through inhibition of MAVS-NLRP3 interaction. J Leucocyte Biol 108(5):1655–1663
Ciminski K, Chase GP, Beer M, Schwemmle M (2021) Influenza a viruses: understanding human host determinants. Trends Mol Med 27(2):104–112
Costa T, Chaves AJ, Valle R, Darji A, van Riel D, Kuiken T et al (2012) Distribution patterns of influenza virus receptors and viral attachment patterns in the respiratory and intestinal tracts of seven avian species. Vet Res 43(1):1–13
Cui D, Zhao D, **e G, Yang X, Huo Z, Zheng S et al (2016) Simultaneous detection of influenza A subtypes of H3N2 virus, pandemic (H1N1) 2009 virus and reassortant avian H7N9 virus in humans by multiplex one-step real-time RT-PCR assay. Springerplus 5(1):1–8
Dadonaite B, Gilbertson B, Knight ML, Trifkovic S, Rockman S, Laederach A et al (2019) The structure of the influenza A virus genome. Nat Microbiol 4(11):1781–1789
De Vries E, Tscherne DM, Wienholts MJ, Cobos-Jiménez V, Scholte F, García-Sastre A et al (2011) Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7(3):e1001329
de Vries E, Du W, Guo H, de Haan CA (2020) Influenza A virus hemagglutinin–neuraminidase–receptor balance: preserving virus motility. Trends Microbiol 28(1):57–67
de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T et al (2010) Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol 84(3):1597–1606
Deng YM, Iannello P, Smith I, Watson J, Barr IG, Daniels P et al (2012) Transmission of influenza A (H1N1) 2009 pandemic viruses in Australian swine. Influenza Other Respir Viruses 6(3):e42–e47
Doud MB, Lee JM, Bloom JD (2018) How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. Nat Commun 9(1):1–12
Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, Ludwig S (2011) The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 392(12):1135–1144
Edinger TO, Pohl MO, Stertz S (2014) Entry of influenza A virus: host factors and antiviral targets. J Gen Virol 95(2):263–277
Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C (2010) The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6(9):e1001099
El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A et al (2011) Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol 186(2):1022–1031
Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V et al (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101(5):1356–1361
Fox A, Quinn KM, Subbarao K (2018) Extending the breadth of influenza vaccines: status and prospects for a universal vaccine. Drugs 78(13):1297–1308
Fukuyama S, Kawaoka Y (2011) The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 23(4):481–486
Furuse Y, Oshitani H (2016) Mechanisms of replacement of circulating viruses by seasonal and pandemic influenza A viruses. Int J Infect Dis 51:6–14
Gales JP, Kubina J, Geldreich A, Dimitrova M (2020) Strength in diversity: nuclear export of viral RNAs. Viruses 12(9):1014
Garcia NK, Guttman M, Ebner JL, Lee KK (2015) Dynamic changes during acid-induced activation of influenza hemagglutinin. Structure 23(4):665–676
Gill JR, Sheng ZM, Ely SF, Guinee DG Jr, Beasley MB, Suh J et al (2010) Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 134(2):235–243
Gillespie L, Roosendahl P, Ng WC, Brooks AG, Reading PC, Londrigan SL (2016) Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN. Sci Rep 6(1):1–11
Goneau LW, Mehta K, Wong J, L’Huillier AG, Gubbay JB (2018) Zoonotic influenza and human health—part 1: virology and epidemiology of zoonotic influenzas. Curr Infect Dis Rep 20:1–12
Gorai T, Goto H, Noda T, Watanabe T, Kozuka-Hata H, Oyama M et al (2012) F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc Natl Acad Sci U S A 109(12):4615–4620
Gounder AP, Boon A (2019) Influenza pathogenesis: the effect of host factors on severity of disease. J Immunol 202(2):341–350
Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG (1999) Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev Biol Stand 98:39–51
Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, Fodor E (2010) The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 84(17):8433–8445
Grant EJ, Quiñones-Parra SM, Clemens EB, Kedzierska K (2016) Human influenza viruses and CD8+ T cell responses. Curr Opin Virol 16:132–142
Gubareva LV, Kaiser L, Hayden FG (2000) Influenza virus neuraminidase inhibitors. Lancet (London, England) 355(9206):827–835. https://doi.org/10.1016/S0140-6736(99)11433-8
Hamilton BS, Whittaker GR, Daniel S (2012) Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses 4(7):1144–1168
Hao W, Wang L, Li S (2020) Roles of the non-structural proteins of influenza A virus. Pathogens 9(10):812
Haque MM, Murale DP, Lee JS (2020) Role of microRNA and oxidative stress in influenza A virus pathogenesis. Int J Mol Sci 21(23):8962
Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293(5536):1840–1842
Herold S, Becker C, Ridge KM, Budinger GS (2015) Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 45(5):1463–1478
Hiscott J, Lin R, Nakhaei P, Paz S (2006) MasterCARD: a priceless link to innate immunity. Trends Mol Med 12(2):53–56
Hoffmann TW, Munier S, Larcher T, Soubieux D, Ledevin M, Esnault E et al (2012) Length variations in the NA stalk of an H7N1 influenza virus have opposite effects on viral excretion in chickens and ducks. J Virol 86(1):584–588
Holzer B, Morgan SB, Martini V, Sharma R, Clark B, Chiu C et al (2019) Immunogenicity and protective efficacy of seasonal human live attenuated cold-adapted influenza virus vaccine in pigs. Front Immunol 10:2625
Hussain M, Galvin HD, Haw TY, Nutsford AN, Husain M (2017) Drug resistance in influenza A virus: the epidemiology and management. Infect Drug Resist 10:121–134
Hutchinson EC, von Kirchbach JC, Gog JR, Digard P (2010) Genome packaging in influenza A virus. J Gen Virol 91(2):313–328
Hutchinson EC, Charles PD, Hester SS, Thomas B, Trudgian D, Martínez-Alonso M, Fodor E (2014) Conserved and host-specific features of influenza virion architecture. Nat Commun 5(1):1–11
Ilyushina NA, Hay A, Yilmaz N, Boon AC, Webster RG, Govorkova EA (2008) Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 52(11):3889–3897
Ingulli E, Mondino A, Khoruts A, Jenkins MK (1997) In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J Exp Med 185(12):2133–2141
Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S et al (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391(10127):1285–1300
Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, ** protein-coding region in influenza A virus segment 3 modulates the host response. Science 337(6091):199–204
Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull Hist Med 76:105–115
Jonges M, Bataille A, Enserink R, Meijer A, Fouchier RA, Stegeman A et al (2011) Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak. J Virol 85(20):10598–10604
Jonges M, Welkers MR, Jeeninga RE, Meijer A, Schneeberger P, Fouchier RA et al (2014) Emergence of the virulence-associated PB2 E627K substitution in a fatal human case of highly pathogenic avian influenza virus A (H7N7) infection as determined by Illumina ultra-deep sequencing. J Virol 88(3):1694–1702
Kamal RP, Alymova IV, York IA (2017) Evolution and virulence of influenza A virus protein PB1-F2. Int J Mol Sci 19(1):96
Kilander A, Rykkvin R, Dudman SG, Hungnes O (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A (H1N1) virus and severe clinical outcome, Norway 2009-2010. Eurosurveillance 15(9):19498
Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis 12(1):9
Kirkpatrick E, Qiu X, Wilson PC, Bahl J, Krammer F (2018) The influenza virus hemagglutinin head evolves faster than the stalk domain. Sci Rep 8(1):1–14
Klomp M, Ghosh S, Mohammed S, Nadeem Khan M (2021) From virus to inflammation, how influenza promotes lung damage. J Leukoc Biol 110(1):115–122
Kong W, Liu Q, Sun Y, Wang Y, Gao H, Liu L et al (2016) Transmission and pathogenicity of novel reassortants derived from Eurasian avian-like and 2009 pandemic H1N1 influenza viruses in mice and Guinea pigs. Sci Rep 6(1):27067
Kreijtz JHCM, Fouchier RAM, Rimmelzwaan GF (2011) Immune responses to influenza virus infection. Virus Res 162(1–2):19–30
Lagace-Wiens PR, Rubinstein E, Gumel A (2010) Influenza epidemiology—past, present, and future. Crit Care Med 38:e1–e9
Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW et al (2009) Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200(4):492–500
Lee MS, Chang PC, Shien JH, Cheng MC, Shieh HK (2001) Identification and subty** of avian influenza viruses by reverse transcription-PCR. J Virol Methods 97(1–2):13–22
Lee BY, Bartsch SM, Willig AM (2012) The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 30(52):7443–7446
Leikina E, Ramos C, Markovic I, Zimmerberg J, Chernomordik LV (2002) Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J 21(21):5701–5710
Leymarie O, Meyer L, Tafforeau L, Lotteau V, Costa BD, Delmas B et al (2017) Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response. J Gen Virol 98(6):1196–1208
Li Q, Sun X, Li Z, Liu Y, Vavricka CJ, Qi J, Gao GF (2012) Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc Natl Acad Sci U S A 109(46):18897–18902
Li ZN, Weber KM, Limmer RA, Horne BJ, Stevens J, Schwerzmann J et al (2017) Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses. J Virol Methods 243:61–67
Liedmann S, Hrincius ER, Guy C, Anhlan D, Dierkes R, Carter R et al (2014) Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions. Nat Commun 5(1):1–8
Lin D, Lan J, Zhang Z (2007) Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin 39(3):155–162
Lina B (2008) History of influenza pandemics. In: Paleomicrobiology: past human infections, pp 199–211
Liu W, Peng L, Liu H, Hua S (2015) Pulmonary function and clinical manifestations of patients infected with mild influenza A virus subtype H1N1: a one- year follow-up. PLoS One 10(7):e0133698
Londrigan SL, Turville SG, Tate MD, Deng YM, Brooks AG, Reading PC (2011) N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol 85(6):2990–3000
Lopez CE, Legge KL (2020) Influenza A virus vaccination: immunity, protection, and recent advances toward a universal vaccine. Vaccine 8(3):434
Lowen AC (2017) Constraints, drivers, and implications of influenza A virus reassortment. Annu Rev Virol 4(1):105–121. https://doi.org/10.1146/annurev-virology-101416-041726
Lowen AC (2018) It’s in the mix: reassortment of segmented viral genomes. PLoS Pathog 14(9):e1007200
Lukens MV, Kruijsen D, Coenjaerts FE, Kimpen JL, van Bleek GM (2009) Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol 83(14):7235–7243
Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101(15):5598–5603
Luo Y, Li L, Austermann-Busch S, Dong M, Xu J, Shao L et al (2015) Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals. J Virol Methods 222:22–27
Ma W, Lager KM, Vincent AL, Janke BH, Gramer MR, Richt JA (2009) The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 56(6–7):326–337
Ma J, Wu R, Xu G, Cheng Y, Wang Z, Wang HA et al (2020) Acetylation at K108 of the NS1 protein is important for the replication and virulence of influenza virus. Vet Res 51:1–10
Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe N (2018) Pandemics: risks, impacts, and mitigation
Mamelund S-E (2011) Geography may explain adult mortality from the 1918–20 influenza pandemic. Epidemics 3(1):46–60, ISSN 1755-4365. https://doi.org/10.1016/j.epidem.2011.02.001
Mancinelli L, Onori M, Concato C, Sorge R, Chiavelli S, Coltella L et al (2015) Clinical features of children hospitalized with influenza A and B infections during the 2012–2013 influenza season in Italy. BMC Infect Dis 16(1):1–8
Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villan E et al (2010) Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6(1):e1000745
Martin KELSEY, Helenius A (1991) Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 65(1):232–244
Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, Warnes C et al (2009) Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J Virol 83(9):4704–4708
Matsuoka Y, Matsumae H, Katoh M, Eisfeld AJ, Neumann G, Hase T et al (2013) A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol 7:1–18
McAuley JL, Gilbertson BP, Trifkovic S, Brown LE, McKimm-Breschkin JL (2019) Influenza virus neuraminidase structure and functions. Front Microbiol 10:39
McMichael AJ (2018) Legacy of the influenza pandemic 1918: the host T cell response. Biomed J 41(4):242–248
Mehle A (2014) Unusual influenza A viruses in bats. Viruses 6(9):3438–3449
Meischel T, Villalon-Letelier F, Saunders PM, Reading PC, Londrigan SL (2020) Influenza A virus interactions with macrophages: lessons from epithelial cells. Cell Microbiol 22(5):e13170
Moghadami M (2017) A narrative review of influenza: a seasonal and pandemic disease. Iran J Med Sci 42(1):2
Mohan H, Narang J, Pundir S, Pundir CS (2021) A changing trend in diagnostic methods of Influenza A (H3N2) virus in human: a review. 3 Biotech 11:1–13
Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P (2008) Interferon-λ contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4(9):e1000151
Mostafa A, Abdelwhab EM, Mettenleiter TC, Pleschka S (2018) Zoonotic potential of influenza A viruses: a comprehensive overview. Viruses 10(9):497. https://doi.org/10.3390/v10090497
Müller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE (2012) Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci 33(2):89–99
Munoz O, De Nardi M, van der Meulen K, Van Reeth K, Koopmans M, Harris K et al (2016) Genetic adaptation of influenza A viruses in domestic animals and their potential role in interspecies transmission: a literature review. EcoHealth 13:171–198
Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y (2013) Identification of novel influenza A virus proteins translated from PA mRNA. J Virol 87(5):2455–2462
Murcia PR, Hughes J, Battista P, Lloyd L, Baillie GJ, Ramirez-Gonzalez RH et al (2012) Evolution of an Eurasian avian-like influenza virus in naive and vaccinated pigs. PLoS Pathog 8(5):e1002730
Nelson M, Viboud C, Vincent A et al (2015a) Global migration of influenza A viruses in swine. Nat Commun 6:6696. https://doi.org/10.1038/ncomms7696
Nelson MI, Stratton J, Killian ML, Janas-Martindale A, Vincent AL (2015b) Continual reintroduction of human pandemic H1N1 influenza A viruses into swine in the United States, 2009 to 2014. J Virol 89(12):6218–6226
Neumann G, Kawaoka Y (2011) The first influenza pandemic of the new millennium. Influenza Other Respir Viruses 5:157–166. https://doi.org/10.1111/j.1750-2659.2011.00231.x
Neumann G, Kawaoka Y (2015) Transmission of influenza A viruses. Virology 479–480:234–246. https://doi.org/10.1016/j.virol.2015.03.009
Neumann G, Hughes MT, Kawaoka Y (2000) Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J 19(24):6751–6758
Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459(7249):931–939
Nieto-Torres JL, Verdiá-Báguena C, Castaño-Rodriguez C, Aguilella VM, Enjuanes L (2015) Relevance of viroporin ion channel activity on viral replication and pathogenesis. Viruses 7(7):3552–3573
Odagiri T, Tobita K (1990) Mutation in NS2, a nonstructural protein of influenza A virus, extragenically causes aberrant replication and expression of the PA gene and leads to generation of defective interfering particles. Proc Natl Acad Sci U S A 87(15):5988–5992
Odagiri T, Tominaga K, Tobita K, Ohta S (1994) An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis. J Gen Virol 75(1):43–53
Ohkura T, Momose F, Ichikawa R, Takeuchi K, Morikawa Y (2014) Influenza A virus hemagglutinin and neuraminidase mutually accelerate their apical targeting through clustering of lipid rafts. J Virol 88(17):10039–10055
Orlich M, Gottwald H, Rott R (1994) Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus. Virology 204(1):462–465
Padilla-Quirarte HO, Lopez-Guerrero DV, Gutierrez-**cotencatl L, Esquivel-Guadarrama F (2019) Protective antibodies against influenza proteins. Front Immunol 10:1677
Pagadala NS (2019) AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase. J Comput Aided Mol Des 33(4):387–404
Perez JT, Varble A, Sachidanandam R, Zlatev I, Manoharan M, García-Sastre A, tenOever BR (2010) Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A 107(25):11525–11530
Pérez LJ, Perera CL, Coronado L, Rios L, Vega A, Frías MT, Ganges L, Núñez JI, de Arce HD (2015) Molecular epidemiology study of swine influenza virus revealing a reassorted virus H1N1 in swine farms in Cuba. Prev Vet Med 119(3–4):172–178. https://doi.org/10.1016/j.prevetmed.2015.02.013
Petrova VN, Russell CA (2018) The evolution of seasonal influenza viruses. Nat Rev Microbiol 16(1):47–60
Piasecka J, Jarmolowicz A, Kierzek E (2020) Organization of the influenza a virus genomic rna in the viral replication cycle—structure, interactions, and implications for the emergence of new strains. Pathogens 9(11):951
Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa, C. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314(5801):997–1001
Pinto LH, Lamb RA (2006) The M2 proton channels of influenza A and B viruses. J Biol Chem 281(14):8997–9000
Pleschka S (2012) Overview of influenza viruses. Swine influenza:1–20
Potter CW et al (2001) A history of influenza. J Appl Microbiol 91(4):572–579
Ravina, Manjeet, Mohan H, Narang J, Pundir S, Pundir CS (2021) A changing trend in diagnostic methods of Influenza A (H3N2) virus in human: a review. 3 Biotech 11(2):87. https://doi.org/10.1007/s13205-021-02642-w
Reading PC, Miller JL, Anders EM (2000) Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74(11):5190–5197
Regea G (2017) Review on influenza virus and its prevention and control. J Vet Med Res 4:1089
Reich S, Guilligay D, Pflug A, Malet H, Berger I, Crépin T et al (2014) Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516(7531):361–366
Reperant LA, Grenfell BT, Osterhaus AD (2015) Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment. Vaccine 33(49):6955–6966
Rodriguez L, Blanco-Lobo P, Reilly EC, Maehigashi T, Nogales A, Smith A et al (2019) Comparative study of the temperature sensitive, cold adapted and attenuated mutations present in the master donor viruses of the two commercial human live attenuated influenza vaccines. Viruses 11(10):928
Rossman JS, Lamb RA (2009) Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe 6(4):299–300
Rossman JS, Lamb RA (2011) Influenza virus assembly and budding. Virology 411(2):229–236
Russell CJ (2014) Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology. Influenza Pathogenesis Control I:93–116
Schaefer R, Zanella JR, Brentano L, Vincent AL, Ritterbusch GA, Silveira S et al (2011) Isolation and characterization of a pandemic H1N1 influenza virus in pigs in Brazil. Pesqui Vet Bras 31(9):761–767
Seladi-Schulman J, Steel J, Lowen AC (2013) Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo. J Virol 87(24):13343–13353
Selman M, Dankar SK, Forbes NE, Jia JJ, Brown EG (2012) Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing. Emerg Microbes Infect 1(1):e42
Shaman J, Kandula S, Yang W, Karspeck A (2017) The use of ambient humidity conditions to improve influenza forecast. PLoS Comput Biol 13(11):e1005844
Shi M, Jagger BW, Wise HM, Digard P, Holmes EC, Taubenberger JK (2012) Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus. J Virol 86(22):12411–12413
Shieh WJ, Blau DM, Denison AM, DeLeon-Carnes M, Adem P, Bhatnagar J et al (2010) 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177(1):166–175
Shiraki K, Daikoku T (2020) Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 209:107512
Shope RE (1931) Swine influenza: III. Filtration experiments and etiology. J Exp Med 54(3):373–385
Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J et al (1995) Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25(4):1125–1128
Simon G, Larsen LE, Dürrwald R, Foni E, Harder T, Van Reeth K et al (2014) European surveillance network for influenza in pigs: surveillance programs, diagnostic tools and Swine influenza virus subtypes identified in 14 European countries from 2010 to 2013. PLoS One 9(12):e115815
Smith W, Andrewes CH, Laidlaw PP (1933) A virus obtained from influenza patients. Lancet 222:66–68
Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W et al (2013) Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19(10):1305–1312
Stauffer S, Feng Y, Nebioglu F, Heilig R, Picotti P, Helenius A (2014) Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol 88(22):13029–13046
Steel J, Lowen AC (2014) Influenza A virus reassortment. Influenza Pathogenesis Control I:377–401
Stegmann T (2000) Membrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion. Traffic 1(8):598–604
Stieneke-Gröber A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C et al (1992) Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11(7):2407–2414
Stuber E, Strober W, Neurath M (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183(2):693–698
Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, Lee CW et al (2004) Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 10(4):693
Subbarao K (2019) The critical interspecies transmission barrier at the animal–human interface. Trop Med Infect Dis 4(2):72
Sun W, Luo T, Liu W, Li J (2020) Progress in the development of universal influenza vaccines. Viruses 12(9):1033
Takemae N, Tsunekuni R, Sharshov K, Tanikawa T, Uchida Y, Ito H, Soda K, Usui T, Sobolev I, Shestopalov A, Yamaguchi T, Mine J, Ito T, Saito T (2017) Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016–2017. Virology 512:8–20. https://doi.org/10.1016/j.virol.2017.08.035
Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S et al (2006) Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 80(13):6218–6224
Talbot HK (2017) Influenza in older adults. Infect Dis Clin 31(4):757–766
Taubenberger JK, Kash JC (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7(6):440–451
Tauber S, Ligertwood Y, Quigg-Nicol M, Dutia BM, Elliott RM (2012) Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo. J Gen Virol 93(4):840–849
Te Velthuis AJ, Fodor E (2016) Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol 14(8):479–493
Teunis PF, Brienen N, Kretzschmar ME (2010) High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission. Epidemics 2(4):215–222
Tobita KSUGIURA, Sugiura A, Enomoto C, Furuyama M (1975) Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol 162:9–14
Tong S, Li Y, Rivailler P, Conrardy C, Castillo DAA, Chen LM et al (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci 109(11):4269–4274
Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9(10):e1003657
Upham JP, Pickett D, Irimura T, Anders EM, Reading PC (2010) Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84(8):3730–3737
Van de Sandt CE, Kreijtz JH, Rimmelzwaan GF (2012) Evasion of influenza A viruses from innate and adaptive immune responses. Viruses 4(9):1438–1476
Vasin AV, Temkina OA, Egorov VV, Klotchenko SA, Plotnikova MA, Kiselev OI (2014) Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. Virus Res 185:53–63
Vemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I (2016) Current approaches for diagnosis of influenza virus infections in humans. Viruses 8(4):96
Vijaykrishna D, Poon LLM, Zhu HC, Ma SK, Li OTW, Cheung CL et al (2010) Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 328(5985):1529–1529
Wang SF, Huang JC, Lee YM, Liu SJ, Chan YJ, Chau YP et al (2008) DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem Biophys Res Commun 373(4):561–566
Wang R, Schwartzman LM, Memoli MJ, Taubenberger JK (2011) Detection of seasonal H3N2 influenza A virus by type-specific TaqMan minor groove binder probe assay. Diagn Microbiol Infect Dis 70(2):281–284
Wang C, Wang Q, Hu J, Sun H, Pu J, Liu J, Sun Y (2017) A multiplex RT-PCR assay for detection and differentiation of avian-origin Canine H3N2, equine-origin H3N8, human-origin H3N2, and H1N1/2009 Canine influenza viruses. PLoS One 12(1):e0170374
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56(1):152–179
White MC, Lowen AC (2018) Implications of segment mismatch for influenza A virus evolution. J Gen Virol 99(1):3
White JM, Wilson IA (1987) Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 105(6):2887–2896
Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56(1):365–394
Wille M, Holmes EC (2020) The ecology and evolution of influenza viruses. Cold Spring Harb Perspect Med 10(7):a038489
Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W et al (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83(16):8021–8031
Wu NC, Wilson IA (2017) A perspective on the structural and functional constraints for immune evasion: insights from influenza virus. J Mol Biol 429(17):2694–2709
Wu NC, Wilson IA (2020) Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med 10(8):a038778
Wu WW, Sun YHB, Panté N (2007) Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol J 4(1):1–12
**ong X, McCauley JW, Steinhauer DA (2014) Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range. Influenza Pathogenesis Control I:63–91
York A, Fodor E (2013) Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA Biol 10(8):1274–1282
Yu D, Vinuesa CG (2010) The elusive identity of T follicular helper cells. Trends Immunol 31(10):377–383
Zhang X, Cunningham FL, Li L, Hanson-Dorr K, Liu L, Waters K et al (2020) Tissue tropisms of avian influenza A viruses affect their spillovers from wild birds to pigs. J Virol 94(24):e00847–e00820
Zhirnov OP, Ikizler MR, Wright PF (2002) Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol 76(17):8682–8689
Zhou L, Li J, Shi D, Xu L, Huang SX (2022) Predicting influenza epidemic for United States. Int J Environ Health Res 32(6):1231–1237
Zmora P, Blazejewska P, Moldenhauer AS, Welsch K, Nehlmeier I, Wu Q et al (2014) DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. J Virol 88(20):12087–12097
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Bhalerao, U. et al. (2023). An Updated Review on Influenza Viruses. In: Bhukya, P.L., Mhaske, S.T., Sonkar, S.C. (eds) Emerging Human Viral Diseases, Volume I. Springer, Singapore. https://doi.org/10.1007/978-981-99-2820-0_2
Download citation
DOI: https://doi.org/10.1007/978-981-99-2820-0_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-2819-4
Online ISBN: 978-981-99-2820-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)